TP53 and gastric cancer: Using a cellular mechanism that involves targeting CASP9 and enhancing the ubiquitination degradation of p53, Jing et al. observed the exosome-transmitted miR-769-5p imparts cisplatin resistance and gastric cancer progression (Jing et al., 2022).